Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




研究发现早期肺癌的蛋白生物标志物

By LabMedica International staff writers
Posted on 05 Jun 2018
美国癌症学会(ACS)估计,2018年美国有154,050人将死于肺癌,世界卫生组织(WHO)表示,全世界有169万例肺癌死亡。
 
大多数肺癌初次确诊时已到晚期,所以肺癌与预后不良相关,是世界范围内癌症相关死亡的首要原因。因此,在可行切除术的早期阶段发现癌症患者极端重要。
 
日本神奈川县北里大学联合医学科学学院(www.kitasato-u.ac.jp)的科学家获得了冷冻的新鲜肺癌组织,并在用于蛋白质组学分析前储藏在-80 °C下。用271名肺癌患者和100名健康对照的血清作为训练集。此外,验证集包括100名肺癌患者和38名健康对照的血清。
 
科研小组开发了单克隆抗体来确证他们的研究。他们还进行了免疫印迹分析,用美国马萨诸塞州伯灵顿市默克公司(www.merckmillipore.com)的Immobilon Western化学发光HRP底物检测膜上的免疫反应带,再用日本东京ATTO公司(www.atto.co.jp)的Cool Saver系统捕获免疫反应带。科研小组还进行了免疫组化染色,在美国加利福尼亚州森尼韦尔市分子器件公司(www.moleculardevices.com)的Genepix 4000B微阵列扫描仪上扫描染色后的涂片,做反相蛋白质阵列(RPPA)分析。
 
在生成的单克隆抗体中,一种命名为KU-Lu-1的抗体识别出细胞骨架相关蛋白4 (CKAP4)。肺癌细胞和组织中检测到CKAP4,还证实它排入培养液的上清液。肺癌患者血清中的CKAP4水平显著高于健康对照者。再者,I期腺癌或鳞状细胞癌患者血清中的CKAP4水平也高于健康对照者。血清CKAP4水平也许能区分肺癌患者与健康对照者,可以在早期检测到,甚至是I期非小细胞肺癌患者。验证集肺癌患者血清中的CKAP4水平也显著高于健康对照者。
 
该研究的论文发表于2018年5月8日的《美国病理学杂志》(The American Journal of Pathology)。资深作者、分子诊断学教授佐藤裕一博士说:“用CKAP4作为生物标志物能改变对肺癌患者的现行治疗惯例,联用CKAP4与常规标志物也许能明显提高诊断准确度。”
 
Related Links:

北里大学联合医学科学学院>>> www.kitasato-u.ac.jp

默克 >>> www.merckmillipore.com

ATTO >>> www.atto.co.jp

分子器件公司>>> www.moleculardevices.com


Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Hybrid Pipette
SWITCH
Pipette
Accumax Smart Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.